Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancerTakashi Furusawa, Urbain Weyemi|Molecular Carcinogenesis|2024Cited by 5
Metabolism-focused CRISPR screen unveils Mitochondrial Pyruvate Carrier 1 as a critical driver for PARP inhibitor resistance in lung cancerTakashi Furusawa, Urbain Weyemi|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0